Healthcare
Live Price
Offline$9.41
+0.00% today
1Y Change
+43.66%
Window
Jun 30, 2025 → Jun 26, 2026
Coverage: 249 bars · Jun 30, 2025 → Jun 26, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sumitomo Pharma Co., Ltd. (DNPUF) is a Healthcare stock with a market cap of $687.11B and listed on OTC. The stock last traded around $9.41 and up 43.7% across the available one-year price window (Jun 30, 2025 → Jun 26, 2026). Baseline metrics include revenue growth of +26.8%, EPS growth of +107.5%, a dividend yield of 0.0%. What stands out right now is revenue +26.8%, EPS +107.5%, free cash flow +101.3% with operating margin 12.9% and ROIC 9.7%. Valuation is more restrained than many high-expectation growth names at P/E 6.2 and price/sales 1.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines DNPUF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
Relative Read
DNPUF is 25.68 pts ahead over the shared 1Y window.
DNPUF had 40.01 pts deeper max drawdown than SPY.
DNPUF beat SPY in 1 of 2 calendar years shown and trailed in 1.
DNPUF
+43.66%
Normalized return
SPY
+17.99%
S&P 500
Excess Return
+25.68 pts
Relative to SPY
DNPUF Max Drawdown
-49.14%
Trailing 1Y
SPY Max Drawdown
-9.13%
Trailing 1Y
Uses the longest available daily history for DNPUF and SPY.
| Year | DNPUF | SPY | Excess | Leader |
|---|---|---|---|---|
| 2026 | -34.47% | +6.71% | -41.18 pts | SPY |
| 2025 | +119.24% | +11.19% | +108.04 pts | DNPUF |
Unable to load analyst forecasts.
Timed out loading forecasts for DNPUF
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.